Tulisokibart Shows Promise in Hidradenitis Suppurativa

(MedPage Today) -- Results from a phase IIb study presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising efficacy with tulisokibart, an investigational tumor necrosis factor-like cytokine 1A (TL1A...